Clinical Trial Update: Patient Controlled Methylphenidate for Cancer Related Fatigue: A Double Blind, Randomized, Placebo Controlled Trial [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of patient-controlled methylphenidate for cancer-related fatigue has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer-related Fatigue

Drugs mentioned

• Methylphenidate (patient-controlled) (Methylphenidate)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Fatigue, Cancer | Phase 3 | Status: COMPLETED